−Removed: Our corporate headquarters, research and development facilities, manufacturing and distribution centers are located in Menlo Park, California.
−Removed: We lease approximately 180,000 square feet under a lease expiring on October 31, 2027.
−Removed: We operate additional research, development and support functions in San Diego, where we lease approximately 73,500 square feet under a lease expiring on September 30, 2027, which was acquired in connection with the acquisition of Omniome.
+Added: Our corporate headquarters, research and development facilities, and manufacturing and distribution centers are located in Menlo Park, California, where we lease approximately 180,200 square feet under a lease expiring on October 31, 2027.
+Added: We operate additional research, development, and support functions in San Diego, where we lease approximately 73,500 square feet under a lease expiring on September 30, 2027.
+Added: Additionally, our European headquarters is located in London, where we lease approximately 7,300 square feet under a lease expiring November 30, 2026.
Including these leases, we lease approximately 275,000 square feet globally.
We believe that our existing facilities, together with suitable additional or alternative space available on commercially reasonable terms, will be sufficient to meet our needs.
−Removed: LEGAL PROCEEDINGS
−Removed: Please see Note 8.
−Removed: Commitments and Contingencies , subsection titled Legal Proceedings , in Part II, Item 8 of this Annual Report on Form 10-K.
−Removed: MINE SAFETY DISCLOSURES
−Removed: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.